|
2025
|
Invention
|
Pharmaceutical compositions and methods for the treatment of metabolic and liver disorders. Discl... |
|
|
Invention
|
Amylin analogs. The present invention encompasses polypeptides of Formula (I), and pharmaceutical... |
|
2024
|
Invention
|
Compositions and methods for the treatment of metabolic and liver disorders. Disclosed herein are... |
|
|
Invention
|
Use of thyroid beta-agonists. Methods useful for treating X-linked adrenoleukodystrophy are provi... |
|
2023
|
Invention
|
Oral dosage forms for the treatment of liver disorders and methods of preparing the same. The pre... |
|
|
Invention
|
Oral dosage forms for the treatment of liver disorders and methods of preparing the same |
|
|
Invention
|
Crystalline forms and methods of producing crystalline forms of a compound. Disclosed herein are ... |
|
|
Invention
|
Compositions and methods for the treatment of metabolic and liver disorders.
Disclosed herein ar... |
|
|
Invention
|
Compositions for the treatment of fibrosis.
The present disclosure is directed to methods of tre... |
|
|
Invention
|
Pharmaceutical formulations and methods for the treatment of metabolic and liver disorders. Discl... |
|
|
Invention
|
Compositions and methods for the treatment of metabolic and liver disorders |
|
|
Invention
|
Thyroid beta-agonist dosing regimens for the treatment of x-ald. The present disclosure relates t... |
|
|
Invention
|
Oral dosage forms of trβ agonist vk2809 for the treatment of liver disorders and methods of prepa... |
|
|
Invention
|
Polymorphic forms and methods of producing polymorphic forms of a compound.
Disclosed herein are... |
|
|
Invention
|
Polymorphic forms and methods of producing polymorphic forms of a compound. Disclosed herein are ... |
|
|
Invention
|
Oral dosage forms of tr.beta. agonist vk2809 for the treatment of liver disorders and methods of ... |
|
|
Invention
|
Pharmaceutical formulations and methods for the treatment of metabolic and liver disorders.
Disc... |
|
2021
|
Invention
|
Compositions and methods for the treatment of liver disorders.
The present disclosure is directe... |
|
|
Invention
|
Compositions and methods for the treatment of liver disorders. The present disclosure is directed... |
|
2020
|
Invention
|
Conjoint therapies with inhibitors of glucose production.
The present invention provides pharmac... |
|
2019
|
Invention
|
Compositions for the treatment of fibrosis and inflammation. The present disclosure is directed t... |
|
2018
|
Invention
|
Compositions for the treatment of fibrosis. The present disclosure is directed to methods of trea... |
|
2017
|
Invention
|
Method of treating glycogen storage disease. The present disclosure provides methods and composit... |
|
|
Invention
|
Method of reducing thyroid-associated side effects.
The present disclosure is directed to method... |
|
|
Invention
|
Method of reducing thyroid-associated side effects. The present disclosure is directed to methods... |
|
|
Invention
|
Compound for use in treating non-alcoholic fatty liver disease in a subject. The present disclosu... |
|
|
Invention
|
Use of thyroid beta-agonists.
Methods useful for treating X-linked adrenoleukodystrophy are prov... |
|
2016
|
Invention
|
Conjoint therapies with inhibitors of glucose production. The present invention provides pharmace... |
|
2015
|
P/S
|
Research on orphan diseases and metabolic and endocrine disorders; research and development of bi... |
